Sandler Capital Management Bio Techne Corp Transaction History

Sandler Capital Management

$698 Million
Q3 2024

A detailed history of Sandler Capital Management transactions in Bio Techne Corp stock. As of the latest transaction made, Sandler Capital Management holds 15,493 shares of TECH stock, worth $1.13 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

15,493

Previous 58,252 73.4%

Holding current value

$1.13 Million

Previous $4.17 Million 70.33%

% of portfolio

0.18%

Previous 0.47%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$70.96 - $82.35 $3.03 Million - $3.52 Million	-42,759 Reduced 73.4%	15,493 $1.24 Million
Q2 2024 Aug 14, 2024	BUY	$62.12 - $84.15 $780,848 - $1.06 Million	12,570 Added 27.52%	58,252 $4.17 Million
Q1 2024 May 15, 2024	SELL	$65.98 - $77.09 $1.35 Million - $1.58 Million	-20,530 Reduced 31.01%	45,682 $3.22 Million
Q4 2023 Feb 14, 2024	BUY	$52.83 - $78.22 $104,497 - $154,719	1,978 Added 3.08%	66,212 $5.11 Million
Q2 2023 Aug 14, 2023	SELL	$73.76 - $85.98 $1.48 Million - $1.72 Million	-20,051 Reduced 23.79%	64,234 $5.24 Million
Q1 2023 May 15, 2023	SELL	$71.62 - $86.62 $6.23 Million - $7.54 Million	-86,995 Reduced 50.79%	84,285 $6.25 Million
Q4 2022 Feb 14, 2023	BUY	$80.67 - $352.29 $12.1 Million - $53 Million	150,493 Added 723.98%	171,280 $14.2 Million
Q3 2022 Nov 14, 2022	BUY	$282.54 - $391.85 $27,406 - $38,009	97 Added 0.47%	20,787 $5.9 Million
Q2 2022 Aug 15, 2022	SELL	$322.67 - $449.65 $45,173 - $62,951	-140 Reduced 0.67%	20,690 $7.17 Million
Q1 2022 May 16, 2022	SELL	$353.85 - $487.79 $14.5 Million - $20 Million	-41,100 Reduced 66.37%	20,830 $9.02 Million
Q4 2021 Feb 14, 2022	SELL	$456.15 - $525.06 $3.06 Million - $3.53 Million	-6,717 Reduced 9.78%	61,930 $32 Million
Q3 2021 Nov 15, 2021	SELL	$444.87 - $538.88 $1.58 Million - $1.92 Million	-3,560 Reduced 4.93%	68,647 $33.3 Million
Q2 2021 Aug 16, 2021	SELL	$387.35 - $450.26 $1.9 Million - $2.21 Million	-4,913 Reduced 6.37%	72,207 $32.5 Million
Q1 2021 May 17, 2021	BUY	$314.62 - $411.0 $8.96 Million - $11.7 Million	28,480 Added 58.55%	77,120 $29.5 Million
Q4 2020 Feb 16, 2021	BUY	$246.9 - $321.87 $2.07 Million - $2.7 Million	8,400 Added 20.87%	48,640 $15.4 Million
Q3 2020 Nov 16, 2020	SELL	$232.22 - $282.96 $5.15 Million - $6.27 Million	-22,160 Reduced 35.51%	40,240 $9.97 Million
Q2 2020 Aug 14, 2020	SELL	$185.43 - $279.56 $619,521 - $934,009	-3,341 Reduced 5.08%	62,400 $16.5 Million
Q1 2020 May 15, 2020	BUY	$161.17 - $221.51 $907,387 - $1.25 Million	5,630 Added 9.37%	65,741 $12.5 Million
Q4 2019 Feb 14, 2020	BUY	$189.68 - $222.09 $3.18 Million - $3.72 Million	16,766 Added 38.68%	60,111 $13.2 Million
Q3 2019 Nov 14, 2019	SELL	$183.56 - $216.72 $1.58 Million - $1.87 Million	-8,611 Reduced 16.57%	43,345 $8.48 Million
Q2 2019 Aug 14, 2019	BUY	$188.72 - $215.43 $2.11 Million - $2.41 Million	11,186 Added 27.44%	51,956 $10.8 Million
Q1 2019 May 15, 2019	BUY	$136.09 - $200.44 $5.55 Million - $8.17 Million	40,770 New	40,770 $8.1 Million
Q4 2018 Feb 14, 2019	SELL	$132.75 - $203.8 $5.19 Million - $7.97 Million	-39,110 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$147.44 - $204.11 $1.62 Million - $2.24 Million	-10,960 Reduced 21.89%	39,110 $7.98 Million
Q2 2018 Aug 14, 2018	SELL	$144.9 - $165.58 $6.08 Million - $6.95 Million	-41,982 Reduced 45.61%	50,070 $7.41 Million
Q1 2018 May 15, 2018	BUY	$131.46 - $151.04 $2.85 Million - $3.28 Million	21,690 Added 30.83%	92,052 $13.9 Million
Q4 2017 Feb 14, 2018	SELL	$121.17 - $134.75 $1.24 Million - $1.37 Million	-10,198 Reduced 12.66%	70,362 $9.12 Million
Q3 2017 Nov 14, 2017	BUY	$113.59 - $123.78 $9.15 Million - $9.97 Million	80,560	80,560 $9.74 Million

Others Institutions Holding TECH

# of Institutions

602

Shares Held

151M

Call Options Held

195K

Put Options Held

53.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.87B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sandler Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Sandler Capital Management with notifications on news.

Account

Sandler Capital Management Bio Techne Corp Transaction History